Sterling Capital Management’s Verve Therapeutics VERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.4K Buy
1,904
+678
+55% +$7.61K ﹤0.01% 1776
2025
Q1
$5.6K Sell
1,226
-1,050
-46% -$4.8K ﹤0.01% 2107
2024
Q4
$12.8K Buy
2,276
+2,026
+810% +$11.4K ﹤0.01% 2051
2024
Q3
$1.21K Buy
+250
New +$1.21K ﹤0.01% 2433